Exchange: NASDAQ·Updated 07:56 PM EDT
CLPT logo

CLPTClearPoint Neuro Inc

$17.77
$0.96
(5.71%)
Today
Closed $17.77
$0.261
(1.47%)
After Hours
EarningsAug 11
Mkt Cap$532.91M
Vol2.08M
News
all
press releases
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
News Placeholder
More News
News Placeholder
Technological Innovations to Wage War Against Some of Medicine's Toughest Diseases
The biotechnology space is delivering a steady stream of potentially market-moving developments this week as companies across oncology, neuroscience, gene therapy, medical devices, and synthetic biology delivered significant regulatory, clinical, and commercial updates. $NTHI, $QURE, $ICCM, $CLPT, $ELTX, $AZTR
24-7 Market News
News Placeholder
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for ClearPoint Neuro (CLPT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
News Placeholder
ClearPoint Neuro Q1 2026 Earnings Call Transcript
read more...
Benzinga
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -16.36% and -1.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +34.78% and +3.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Wednesday
ClearPoint Neuro (NASDAQ:CLPT) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-clearpoint-neuro-inc-stock...
MarketBeat
News Placeholder
UFP Technologies (UFPT) Tops Q1 Earnings Estimates
UFP (UFPT) delivered earnings and revenue surprises of +13.76% and -2.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3% - Should You Sell?
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3% - What's Next...
MarketBeat
News Placeholder
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March
ClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) saw a large growth in short interest in March. As of March 13th, there was short interest totaling 4,288,498 shares, a growth of 29.0% from the...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.